EFA develops RevDx- The First Affordable Hand-Held Device for on-the-spot CBC tests (Complete Blood Count) with no expertise required.

CBC is the most requested test worldwide and physician’s “best practice”. Helps diagnosing infectious diseases, hematological malignancies and immune system deficiencies.

EFA’s diagnostic system addresses the global need to minimize the overuse of antibiotics and combines several advantages of ease of use and advanced technology, including a simple operation that does not require special training, and a connective and fully portable device.

EfA’s product: RevDx (Revolutionary Diagnostics), is a mobile, portable, handheld, end-point solution that includes an innovative method to perform an automatic computerized “microscopy like” inspection, including a whole blood sampling and an automatic diagnosis of blood count and other applications to be followed.